GSK3745417 clinical trials

A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors

This study is testing a new medicine, GSK3745417, alone or with another drug, dostarlimab, for people with advanced cancers. The aim is to see if it's safe, how well it's tolerated, find the right dose, and check its early effects against cancer.